StockVS

NASDAQ · Medical Instruments & Supplies · USD

Lucyd, Inc (LUCY) Stock Analysis

Lucyd, Inc (LUCY) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

LUCY

$0.93

+$0.03 (+2.76%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LUCY with… →

LUCY Key Statistics

As of Sep 4, 2026
Trading
Open
$0.91
Previous Close
$0.91
Day's Range
0.88–0.93
52-Week Range
0.65–2.24
Volume
271.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.75
Valuation
Market Cap
$8.01M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
2.35
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.19
Financials (FY)
Revenue (FY)
$2.66M+62.65%
Net Income (FY)
−$7.59M
Profit marginThe share of revenue left as profit after all costs and taxes.
−225.28%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
8.61M
1-Year Return
−50.27%
Dividend and dates
Earnings Date
November 12, 2026estimated
Avg Volume
7.93M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LUCY Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−6.72%
2025−79.74%
2024−41.71%
2023−69.20%
2022 (partial year)−76.74%

As of September 4, 2026.

LUCY Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$2.66M−$7.59M−285.2%
2024$1.64M−$7.77M−474.6%
2023$1.15M−$6.66M−578.2%
2022$659.79K−$5.68M−861.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$2.66M$567.45K−$8.49M−$7.59M−285.2%
2024$1.64M$215.19K−$7.92M−$7.77M−474.6%
2023$1.15M−$119.33K−$6.86M−$6.66M−578.2%
2022$659.79K−$56.29K−$5.58M−$5.68M−861.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LUCY Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricLUCYMedical Instruments & Supplies medianvs median
P/S ratio2.353.1726% below
Profit margin−225.28%0.85%226.1 pts below

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Lucyd, Inc (LUCY) carries a market capitalisation of $8.01M. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. Headcount on file is 13.

Over the past 52 weeks the price has ranged from $0.65 to $2.24. The most recent close on file for LUCY is $0.93, dated September 4, 2026. That is +$0.03 (+2.76%) against the previous close. The latest close sits 43.08% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $2.66M. That is +62.65% against the prior fiscal year, when revenue was $1.64M. The same year closed with a net loss of $7.59M. Profit margin runs at −225.28%. That is 226.1 percentage points below the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to −1.19.

Across the 4 fiscal years on file, revenue moves from $659.79K in 2022 to $2.66M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 2.35 times revenue. On price-to-sales that is 26.05% below the Medical Instruments & Supplies median of 3.17. The medians here are taken across 55 Medical Instruments & Supplies companies that report the metric.

The trailing one-year price return is −50.27%. Measured over 3 years, that is −58.25% a year compounded. The reported beta is 2.75. Daily returns over the trailing 4 years annualize to a volatility of 285.85%.

Growth & Income

No dividend is on file for LUCY.

2026 is still running; the price is −6.72% year to date. Across the complete calendar years on file, 2024 returned −41.71% and 2025 returned −79.74%. Of the 3 complete calendar years on file, 0 finished higher.

Peer Comparison

Lucyd, Inc (LUCY) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Lucyd, Inc LUCY $8.01M
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. Lucyd, Inc has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Lucyd, Inc

Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.

Visit website →